PATENT CLAIM ANALYSIS

Application Number: 16061279
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "259410"]

Abstract:
Disclosed in the present invention are a crystalline Form of pyrido[1,2-a]pyrimidone analog, a preparation method therefor and an intermediate thereof,

Claim (Index 36):
A method for preparing Compound 1 as represented by the following formula, comprising, the following steps, wherein\n X is selected from Cl or Br; \n alkali C is selected from pyridine, 2,6-lutidine, Et 3 N, 4-DMAP, LiOH, Cs 2 CO 3 , or K 2 CO 3 ; \n solvent c is selected from pyridine, dichloromethane, toluene, acetonitrile, acetone, DMF or THF; \n a molar ratio of Compound 7 to Compound 8 is 1:1-3; \n a molar ratio of Compound 7 to alkali C is 1:1-3.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15504018', '15539147', '16331915', '12559927', '16343165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7891759370369581
- 35 USC 102 Novelty (BERT): 0.5243335453653025
- Combined Prediction Score: 0.7626916978697926
- Mean Citation Score: 323.776176
- Max Citation Score: 338.88705
- Similarity Product: 241.98878029636143

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test